WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 4'3601 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 11'0921 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 10'997  10'875  10'753  10'632  10'511  9'553  8'135  6'308 
Births 190  189  188  187  185  166  219  229 
Surviving infants 187  186  185  184  182  161  210  210 
Pop. less than 5 years 925  918  905  886  871  832  1'066  993 
Pop. less than 15 years 2'552  2'528  2'510  2'498  2'500  2'850  3'099  2'646 
Female 15-49 years 3'079  3'073  3'062  3'046  3'023  2'635  1'981  1'480 

Number of reported case

(Click for retrospective incidence data for Tunisia)
Diphtheria
Japanese encephalitis
Measles 16  48  11  47  547  225 
Mumps
Pertussis 88  68  4'106 
Polio* 15 
Rubella 15  615  1'075  164  98 
Rubella (CRS) 18 
Tetanus (neonatal) 13 
Tetanus (total) 12  121 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Tunisia)
Vaccine year result method % card seen                                                
BCG 2010  98  MICS   84  97  99  98  98  98  95  88  65 
DTP1 2010  99  MICS   84  99  99  98  98  99  94 
DTP3 2010  96  MICS   84  98  97  98  98  99  97  91  36 
HepB_BD          82  73  80  82  88 
HepB3 2010  92  MICS   84  98  97  98  98  99  88 
Hib3 2005  100  MICS     98  97  43 
JapEnc         
MCV 2010  94  MICS   84  94  96  96  97  98  85  88  65 
MCV2          98  96  96  98  97  98 
PCV1         
PCV3         
Pol3 2010  94  MICS   84  98  97  98  98  99  97  91  37 
Rota1         
Rota_last         
Rubella1          94  96  92  97  93 
TT2plus 2010  12  MICS   84  90  95  93  87  32 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Tunisia)
BCG 97  99  98  98  98  95  96 
DTP1 99  99  98  98  99  99  97 
DTP3 98  97  98  98  99  97  93 
HepB3 98  97  98  98  99  94 
HepB_BD 82  73  80  82  88 
Hib3 98  97  43 
MCV 94  96  96  97  98  95  93 
MCV2 98  96  96  98  97  98 
PAB 96  96  96  96  96  68  40 
PCV3
Pol3 98  97  98  98  99  97  93 
Rota_last

Number of districts in the country 225  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 92
From 80 to 89% 8
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT Yes If pertussis contrindication
DTwP 18 months; Yes
DTwPHibHepB 2, 3, 6 months; Yes
HepB birth; Yes
MR 12, 18 months; 6, 12 years; Yes
OPV 2, 3, 6 months; 6, 12, 18 years; Yes
Rubella Yes Post-partum
Td 7, 12, 18 years; Yes and CBAW

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  No  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2018  2013-2018      2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 225  225  225  225  225  225  225 
Nº districts with DTP3 coverage >=80% number 225  225  224  225  225  225  16 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 191  164  154  177  192  182   
% of districts with MCV1 coverage >=95% From 0 to 100% 85  73  68  79  85  81   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100    100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.